Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

Boehringer Ingelheim headquarters

Boehringer says anti-IL-23 drug beats Stelara in psoriasis trial

Interleukin-23 inhibitor outperforms Johnson & Johnson's blockbuster

National Institute for Health and Care Excellence NICE logo

NICE recommends Keytruda for advanced skin cancer

Second recommendation for drug in a week

- PMLiVE

Neurocrine plans movement disorder drug filing in 2016

NBI-98854 in trials for tardive dyskinesia

Ritter Pharmaceuticals appoints new CMO

AnnKatrin Petersen-Jappelli to strengthen company

Blue-Latitude-Health-logo-small

10 tips for developing insightful pre-launch positioning

By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Blue Latitude Health's Head...

Blue Latitude Health

- PMLiVE

Boehringer takes a mega pair of lungs on tour

Welshawareness campaign aims help tackle the country's poor cancer record

- PMLiVE

BMS recruits Jack Huston for European Lung cancer campaign

TheBoardwalk Empire actor will work with the firm on an awareness drive

- PMLiVE

Oliver Group buys digital agency Dare

The firm's clients include Public Health England and Cancer Research UK

Eli Lilly HQ

Lilly wins breakthrough designation for breast cancer drug

CDK 4 and 6 inhibitor Abemaciclib's development to be expedited by FDA

- PMLiVE

FDA fast-tracks Merck/Pfizer’s rare skin cancer drug avelumab

Comes a month after drug was given orphan status

Osmotica Pharmaceuticals appoints new vice president

Samer Kaba joins the firm

- PMLiVE

Indian court blocks generic of Merck’s Januvia

Follows a series of setbacks in Indian courts for multinational pharma companies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links